Biologic drugs help treat devastating illnesses such as inflammatory bowel disease (IBD). However, it’s important to understand the return on investment for these medications goes beyond the cost of the products.
Instead of worrying about short-term noise in the market, investors should focus on long-term outcomes, says Sandy McIntyre, vice-chairman of Sentry Investments.
How to handle the payout phase is one of the most important issues facing DC plan sponsors today. Benefits Canada’s 2015 DC Plan Summit delved into the decumulation dilemma.
Retirement today is far more complex and unpredictable than it’s been in the past.